David P. Al-Adra, MD, PhD, FACS

Assistant Professor

  • Division of Transplantation 

(608) 263-0388

Clinical Science Center
600 Highland Avenue
Madison WI 53792


  • MD, University of Alberta, 2007
  • PhD, Clinical Investigator Program in the Department of Surgery, University of Alberta, 2012
  • Residency, General Surgery, University of Alberta, 2015
  • Abdominal Organ Transplant Fellowship, University of Toronto, 2017

Clinical Specialties

Dr. Al-Adra is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS), the Royal College of Surgeons of Canada, and the Americas Hepato-Pancreato-Biliary Association (AHPBA). He specializes in liver, kidney, pancreas and pediatric transplantation, live donor liver transplantation (LDLT), and hepatobiliary surgery.

Research Interests

Dr. Al-Adra is investigating the mechanisms of immunological rejection after solid organ transplantation. The goal of his research is to decrease the immune response against the organ, which would then decrease the need for anti-rejection drugs. Specifically, the transplanted organs can be modified using normothermic machine organ preservation technologies to decrease rejection after transplantation.

Learn more about Dr. Al-Adra’s lab here. 

Recent Publications

  • Quantifying the immune response to a tissue-engineered porcine extracellular matrix.
    El-Andari R, Bozso SJ, Jh Kang J, Fialka NM, Al-Adra D, Meyer SR, Moon MC, Freed DH, Nagendran J, Nagendran J
    Regen Med 2023 Mar; 18(3): 229-237
    [PubMed ID: 36691822]

  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
    Bhat M, Dondossola D, Varghese R, Czigany Z, Emamaullee J, Ghinolfi D, Al-Adra D, Bonaccorsi-Riani E, Pang L, Boteon YL, Brüggenwirth I, Pavan-Guimaraes J, Ho CM, Yuksel M, Zarrinpar A, Abdelrahim M, Barbas AS, Mas V, Selzner M, Martins PN
    Transplantation 2022 Dec 23;
    [PubMed ID: 36550624]

  • Neoadjuvant Chemotherapy Plus Living Donor Transplantation (LDLT) for Non-Resectable Liver Metastases from Colorectal Cancer (CRC).
    Lambdin J, Ryan CE, Alejandro RH, Baker T, Sapisochin G, Hernandez JM, Al-Adra DP
    Ann Surg Oncol 2023 Jan; 30(1): 18-20
    [PubMed ID: 36316505]

  • Blood products and liver transplantation: A strategy to balance optimal preparation with effective blood stewardship.
    Little CJ, Leverson GE, Hammel LL, Connor JP, Al-Adra DP
    Transfusion 2022 Oct; 62(10): 2057-2067
    [PubMed ID: 35986654]

  • A master surgical educator: the "intrinsic" factor of Dr. Paul Greig.
    Al-Adra DP, Barbas AS, Shah S, Molinari M
    HPB (Oxford) 2022 Nov; 24(11): 1821-1822
    [PubMed ID: 36002362]

All Publications on PubMed